Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lupus anticoagulant-hypoprothrombinemia syndrome with severe bleeding diathesis after coronavirus disease 2019: a case report. | Croat Med J | 2022 | 36325674 | PubTator, text mining | PubMed |
| Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease. | Gastroenterol Hepatol Bed Bench | 2022 | 36311966 | PubTator, text mining | PubMed |
| Historical Perspectives and Evolution of Menstrual Terminology. | Front Reprod Health | 2022 | 36303670 | PubTator, text mining | PubMed |
| Data mining for prothrombin time and international normalized ratio reference intervals in children. | PLoS One | 2022 | 36302050 | PubTator, text mining | PubMed |
| Exploratory analysis of interleukin-38 in hospitalized COVID-19 patients. | Immun Inflamm Dis | 2022 | 36301025 | PubTator, text mining | PubMed |
| Coagulation Profile of COVID-19 Patients. | Life (Basel) | 2022 | 36295093 | PubTator, text mining | PubMed |
| A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab. | J Clin Med | 2022 | 36294464 | PubTator, text mining | PubMed |
| Components of the Complement Cascade Differ in Polycystic Ovary Syndrome. | Int J Mol Sci | 2022 | 36293087 | PubTator, text mining | PubMed |
| Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population. | Genes (Basel) | 2022 | 36292752 | PubTator, text mining | PubMed |
| A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review. | Diagnostics (Basel) | 2022 | 36292248 | PubTator, text mining | PubMed |
| Reference Intervals for Coagulation Parameters in Developmental Hemostasis from Infancy to Adolescence. | Diagnostics (Basel) | 2022 | 36292241 | PubTator, text mining | PubMed |
| Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trial. | Front Cardiovasc Med | 2022 | 36277757 | PubTator, text mining | PubMed |
| Specificity of oligonucleotide gene therapy (OGT) agents. | Theranostics | 2022 | 36276652 | PubTator, text mining | PubMed |
| The relationship between radiomics and pathomics in Glioblastoma patients: Preliminary results from a cross-scale association study. | Front Oncol | 2022 | 36276163 | PubTator, text mining | PubMed |
| Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis. | Vasc Health Risk Manag | 2022 | 36268462 | PubTator, text mining | PubMed |
| A new human-inspired metaheuristic algorithm for solving optimization problems based on mimicking sewing training. | Sci Rep | 2022 | 36253404 | PubTator, text mining | PubMed |
| Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke. | Nat Commun | 2022 | 36253349 | PubTator, text mining | PubMed |
| Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis. | Front Oncol | 2022 | 36249025 | PubTator, text mining | PubMed |
| Exploring the Complex Network of Heme-Triggered Effects on the Blood Coagulation System. | J Clin Med | 2022 | 36233841 | PubTator, text mining | PubMed |
| Pulmonary Embolism in the Cancer Associated Thrombosis Landscape. | J Clin Med | 2022 | 36233519 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=32